1 / 17

Development within Novartis

gerard
Download Presentation

Development within Novartis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Development within Novartis Conference European Institute for Industrial Leadership Erik Karlman, Efficiency Engineer Terrassa, October 15th 2008

    2. 2 | Development within Novartis EIIL | Erik Karlman | 15 Oct 2008 | Terrassa | Agenda

    3. 3 | Development within Novartis EIIL | Erik Karlman | 15 Oct 2008 | Terrassa |

    4. 4 | Development within Novartis EIIL | Erik Karlman | 15 Oct 2008 | Terrassa | Novartis in Summary WHO WE ARE: Overview slide to position us globally, introduce core themes, explain how we differentiate ourselves. Sales ranking is by IMS-Health on rolling basis, July 2005-July 2006 – we have overtaken Sanofi (only Pfizer and GSK ahead). Based on total pharmaceutical sales – includes Sandoz and OTC. Market capitalization: studies including FT500 Reputation: FT World’s Most Respected Companies (49 in 2006), Business Week (top 50 brands) plus many Best Place to Work rankings (i.e. Fortune, The Scientist). WHO WE ARE: Overview slide to position us globally, introduce core themes, explain how we differentiate ourselves. Sales ranking is by IMS-Health on rolling basis, July 2005-July 2006 – we have overtaken Sanofi (only Pfizer and GSK ahead). Based on total pharmaceutical sales – includes Sandoz and OTC. Market capitalization: studies including FT500 Reputation: FT World’s Most Respected Companies (49 in 2006), Business Week (top 50 brands) plus many Best Place to Work rankings (i.e. Fortune, The Scientist).

    5. 5 | Development within Novartis EIIL | Erik Karlman | 15 Oct 2008 | Terrassa | Recognized as a great place to work EMPLOYEE REPUTATION: Links back to second pillar of CC and underscores business case: - Novartis competes as a global player on global markets (clients, products, resources, relationships, etc.) and must meet the international (not just local) standards for work place design. - The aspiration to create a ‘Best Place to Work’ will become a symbol of Novartis’ commitment to be a leading pharmaceutical company and to attract and retain e.g. the best people in R&D and marketing. Objective: Create optimum conditions for researchers and knowledge workers. EMPLOYEE REPUTATION: Links back to second pillar of CC and underscores business case: - Novartis competes as a global player on global markets (clients, products, resources, relationships, etc.) and must meet the international (not just local) standards for work place design. - The aspiration to create a ‘Best Place to Work’ will become a symbol of Novartis’ commitment to be a leading pharmaceutical company and to attract and retain e.g. the best people in R&D and marketing. Objective: Create optimum conditions for researchers and knowledge workers.

    6. 6 | Development within Novartis EIIL | Erik Karlman | 15 Oct 2008 | Terrassa | Agenda

    7. 7 | Development within Novartis EIIL | Erik Karlman | 15 Oct 2008 | Terrassa |

    8. 8 | Development within Novartis EIIL | Erik Karlman | 15 Oct 2008 | Terrassa |

    9. 9 | Development within Novartis EIIL | Erik Karlman | 15 Oct 2008 | Terrassa | Agenda

    10. 10 | Development within Novartis EIIL | Erik Karlman | 15 Oct 2008 | Terrassa | Graduate Manufactoring Program (gMP) Objectives of the program To increase the talent pipeline by engaging the best talent for future succession planning in Pharmaceutical Operations (PharmOps) Engrain a global outlook through practical experiences by promoting mobility of talent as well as flexibility in disciplines Promote cultural diversity in moving towards a global organisation Feed into the concept of “process orientation” by cultivating a process oriented thinking style

    11. 11 | Development within Novartis EIIL | Erik Karlman | 15 Oct 2008 | Terrassa | Graduate Manufactoring Program (gMP) Why I was attracted.. Well-known company with good employer reputation Multinational company providing opportunity for international work experience as well as improving language skills Trainee-program with possibilities to broaden my knowledge in non-technical areas, cross-functional tasks Excellent opportunities for networking Programs in place for further career development

    12. 12 | Development within Novartis EIIL | Erik Karlman | 15 Oct 2008 | Terrassa | Graduate Manufactoring Program (gMP) How is the gMP set up? 24 month program running at PharmOps site 1st year “Home Country” (in my case Spain) Introduction covering processes and products with some operational work and responsibility plus small projects Technical Learning 2nd year rotation to a plant in Europe or USA (in my case Germany) Understand how to work on a different site/operation Learn to work in a different cultural environment Undertake small projects Assistant Job in Line

    13. 13 | Development within Novartis EIIL | Erik Karlman | 15 Oct 2008 | Terrassa | Graduate Manufactoring Program (gMP) gMP Profile Minimum of B.Sc. in Chemistry, Pharmacy or Engineering “Fresh” from university Business awareness Good language skills Mobile and willing to relocate for 12 months Wants to make a difference Adaptable with drive Good communication and interpersonal skills Technical expertise

    14. 14 | Development within Novartis EIIL | Erik Karlman | 15 Oct 2008 | Terrassa | Graduate Manufactoring Program (gMP) Benefits to Selected Candidates Opportunity for career growth within a successful global business Competitive salary and benefits package International experience within a global pharmaceutical company Learning managed through a structured competency development plan Regular appraisals focussed on personal progress, performance and development Close contact and visibility to TechOps Top Management

    15. 15 | Development within Novartis EIIL | Erik Karlman | 15 Oct 2008 | Terrassa | Graduate Manufactoring Program (gMP) Benefits from my time as a gMP Understanding of culture in different work environments and countries Improved my language skills Work experience and training in different areas of the business Broader understanding of the business, for instance key drivers Insight into the global organisation and knowledge of how functions are connected to eachother Networking - Contacts at different sites as well as in other areas areas of the company

    16. 16 | Development within Novartis EIIL | Erik Karlman | 15 Oct 2008 | Terrassa | Summary: Talent Development Prgs in PharmOps

    17. QUESTIONS ? Thank you very much!

More Related